uniQure NV (QURE)
23.81
-0.82
(-3.33%)
USD |
NASDAQ |
Nov 13, 16:00
23.81
0.00 (0.00%)
After-Hours: 19:59
uniQure Shareholders Equity (Quarterly) : 294.65M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 294.65M |
| June 30, 2026 | 324.05M |
| March 31, 2026 | 149.34M |
| December 31, 2025 | 198.90M |
| September 30, 2025 | 228.75M |
| June 30, 2025 | -4.003M |
| March 31, 2025 | 33.69M |
| December 31, 2024 | -6.752M |
| September 30, 2024 | 55.82M |
| June 30, 2024 | 97.11M |
| March 31, 2024 | 146.75M |
| December 31, 2023 | 207.67M |
| September 30, 2023 | 268.78M |
| June 30, 2023 | 353.32M |
| March 31, 2023 | 412.77M |
| December 31, 2022 | 476.01M |
| September 30, 2022 | 421.17M |
| June 30, 2022 | 486.49M |
| March 31, 2022 | 546.00M |
| December 31, 2021 | 595.78M |
| September 30, 2021 | 590.76M |
| June 30, 2021 | 633.61M |
| March 31, 2021 | 228.69M |
| December 31, 2020 | 243.90M |
| September 30, 2020 | 227.89M |
| Date | Value |
|---|---|
| June 30, 2020 | 265.50M |
| March 31, 2020 | 295.15M |
| December 31, 2019 | 323.06M |
| September 30, 2019 | 350.23M |
| June 30, 2019 | 132.06M |
| March 31, 2019 | 157.11M |
| December 31, 2018 | 179.61M |
| September 30, 2018 | 199.85M |
| June 30, 2018 | 218.42M |
| March 31, 2018 | 100.26M |
| December 31, 2017 | 89.36M |
| September 30, 2017 | 19.61M |
| June 30, 2017 | 27.29M |
| March 31, 2017 | 48.91M |
| December 31, 2016 | |
| September 30, 2016 | 81.34M |
| June 30, 2016 | 94.77M |
| March 31, 2016 | 115.40M |
| December 31, 2015 | 129.80M |
| September 30, 2015 | 145.62M |
| June 30, 2015 | 130.84M |
| March 31, 2015 | 36.27M |
| December 31, 2014 | 52.13M |
| September 30, 2014 | 64.68M |
| June 30, 2014 | 75.73M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cartesian Therapeutics, Inc. | -130.47M |
| Moderna, Inc. | 6.837B |
| GRAIL, Inc. | 2.454B |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 940.55M |
| Total Liabilities (Quarterly) | 645.90M |
| Debt to Equity Ratio | 1.916 |
| Current Ratio | 11.52 |
| Net Debt Paydown Yield | -0.50% |